These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18026888)

  • 1. Networking for rare diseases: a necessity for Europe.
    Aymé S; Schmidtke J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Dec; 50(12):1477-83. PubMed ID: 18026888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The European Union Policy in the Field of Rare Diseases.
    Moliner AM; Waligora J
    Adv Exp Med Biol; 2017; 1031():561-587. PubMed ID: 29214592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Orphanet and its consortium: where to find expert-validated information on rare diseases].
    Maiella S; Rath A; Angin C; Mousson F; Kremp O
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S3-8. PubMed ID: 23452769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National registries of rare diseases in Europe: an overview of the current situation and experiences.
    Taruscio D; Vittozzi L; Choquet R; Heimdal K; Iskrov G; Kodra Y; Landais P; Posada M; Stefanov R; Steinmueller C; Swinnen E; Van Oyen H
    Public Health Genomics; 2015; 18(1):20-5. PubMed ID: 25228300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
    Parker S
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for the European platform for rare disease registries.
    Vittozzi L; Gainotti S; Mollo E; Donati C; Taruscio D
    Public Health Genomics; 2013; 16(6):299-304. PubMed ID: 24503590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Policies and actions to tackle rare diseases at European level.
    Montserrat A; Taruscio D
    Ann Ist Super Sanita; 2019; 55(3):296-304. PubMed ID: 31553326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creating a European Union framework for actions in the field of rare diseases.
    Moliner AM
    Adv Exp Med Biol; 2010; 686():457-73. PubMed ID: 20824460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare diseases and orphan drugs.
    Taruscio D; Capozzoli F; Frank C
    Ann Ist Super Sanita; 2011; 47(1):83-93. PubMed ID: 21430345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rare pulmonary diseases: from the adoption of orphan diseases to structured healthcare networks].
    Cottin V; Cordier JF
    Rev Mal Respir; 2014 Dec; 31(10):889-92. PubMed ID: 25465349
    [No Abstract]   [Full Text] [Related]  

  • 11. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data.
    Groft SC; Posada de la Paz M
    Adv Exp Med Biol; 2017; 1031():3-21. PubMed ID: 29214563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The European union policy in the field of rare diseases.
    Montserrat Moliner A; Waligóra J
    Public Health Genomics; 2013; 16(6):268-77. PubMed ID: 24503587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare Diseases in Europe: from a Wide to a Local Perspective.
    Baldovino S; Moliner AM; Taruscio D; Daina E; Roccatello D
    Isr Med Assoc J; 2016 Jun; 18(6):359-63. PubMed ID: 27468531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Orphanet and the Dutch Steering Committee Orphan Drugs. A European and Dutch databank of information on rare diseases].
    Liem SL
    Ned Tijdschr Tandheelkd; 2008 Nov; 115(11):621-3. PubMed ID: 19058507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How the EUCERD Joint Action supported initiatives on Rare Diseases.
    Lynn S; Hedley V; Atalaia A; Evangelista T; Bushby K;
    Eur J Med Genet; 2017 Mar; 60(3):185-189. PubMed ID: 28087401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The context for the thematic grouping of rare diseases to facilitate the establishment of European Reference Networks.
    Evangelista T; Hedley V; Atalaia A; Johnson M; Lynn S; Le Cam Y; Bushby K
    Orphanet J Rare Dis; 2016 Feb; 11():17. PubMed ID: 26911987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EUROCOURSE recipe for cancer surveillance by visible population-based cancer RegisTrees in Europe: From roots to fruits.
    Coebergh JW; van den Hurk C; Louwman M; Comber H; Rosso S; Zanetti R; Sacchetto L; Storm H; van Veen EB; Siesling S; van den Eijnden-van Raaij J
    Eur J Cancer; 2015 Jun; 51(9):1050-63. PubMed ID: 25934439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tackling rare diseases at European level: why do we need a harmonized framework?
    Taruscio D; Trama A; Stefanov R
    Folia Med (Plovdiv); 2007; 49(1-2):59-67. PubMed ID: 18018471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Orphanet: a European database for rare diseases].
    Weinreich SS; Mangon R; Sikkens JJ; Teeuw ME; Cornel MC
    Ned Tijdschr Geneeskd; 2008 Mar; 152(9):518-9. PubMed ID: 18389888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undiagnosed Diseases: Italy-US Collaboration and International Efforts to Tackle Rare and Common Diseases Lacking a Diagnosis.
    Taruscio D; Floridia G; Salvatore M; Groft SC; Gahl WA
    Adv Exp Med Biol; 2017; 1031():25-38. PubMed ID: 29214564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.